Breast Cancer Update cover image

Meet The Professor: Optimizing the Management of ER-Positive and Triple-Negative Breast Cancer — Part 1 of a 3-Part Series

Breast Cancer Update

00:00

Is DXD a Second Line Therapy for Lung Cancer?

TDXD could very well become second line therapy and lung cancer, incidentally. Of course, all these agents with the last name of DXD, one issue you have to think a little bit about or a lot about is an ILD. We were asking people how they screened for it in patients on TDXD. You know, is it just asking for a sentence?

Play episode from 56:16
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app